relative dose intensity

You have access
The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate Cancer
FUMIHIKO URABE, DAIGO KOBAYASHI, KOSUKE IWATANI, YU IMAI, HAJIME ONUMA, KOICHI AIKAWA, TAKAFUMI YANAGISAWA, KOJIRO TASHIRO, HIROSHI SASAKI, JUN MIKI, KENTA MIKI and TAKAHIRO KIMURA

Anticancer Research October 2023, 43 (10) 4611-4617; DOI: https://doi.org/10.21873/anticanres.16655
You have access
Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin Treatment
YOSHITAKA SAITO, YOH TAKEKUMA, TAKASHI TAKESHITA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA

Anticancer Research July 2022, 42 (7) 3693-3700; DOI: https://doi.org/10.21873/anticanres.15858
You have access
Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
HAJIME MATSUSHIMA, TOMOHIKO ADACHI, MASAAKI HIDAKA, MAMPEI YAMASHITA, TAKASHI HAMADA, SAEKO FUKUI, TAKAYUKI TANAKA, HAJIME IMAMURA, KYOHEI YOSHINO, TOTA KUGIYAMA, AMANE KITASATO, TAKANOBU HARA, AKIHIKO SOYAMA, KAZUMA KOBAYASHI, YORIHISA SUMIDA, TAMOTSU KUROKI and SUSUMU EGUCHI

Anticancer Research June 2022, 42 (6) 3133-3141; DOI: https://doi.org/10.21873/anticanres.15802
You have access
Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis
KANAKO MAMISHIN, YOICHI NAITO, SHOGO NOMURA, GAKUTO OGAWA, KUMI NIGUMA, KAEDE BABA, SAEKO SAKAEDA, HIROMICHI NAKAJIMA, SHOTA KUSUHARA, CHIKAKO FUNASAKA, TAKEHIRO NAKAO, YOKO FUKASAWA, CHIHIRO KONDOH, KENICHI HARANO, TAKAHIRO KOGAWA, NOBUAKI MATSUBARA, AKO HOSONO, TOSHIKATSU KAWASAKI and TORU MUKOHARA

Anticancer Research December 2021, 41 (12) 6217-6224; DOI: https://doi.org/10.21873/anticanres.15441
You have access
Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib
RYU SASAKI, MASANORI FUKUSHIMA, MASAFUMI HARAGUCHI, SATOSHI MIUMA, HISAMITSU MIYAAKI, MASAAKI HIDAKA, SUSUMU EGUCHI, SATOSHI MATSUO, TOSHIHISA MATSUZAKI, SATSUKI HASHIMOTO, KAZUO OHBA, YUKI KUGIYAMA, HIROSHI YATSUHASHI, HIDETAKA SHIBATA, YASUHIDE MOTOYOSHI, MASAYA SHIGENO, SHINICHI IWATSU, YUJI KATO, NOBORU KINOSHITA and KAZUHIKO NAKAO

Anticancer Research April 2021, 41 (4) 2025-2032; DOI: https://doi.org/10.21873/anticanres.14970
You have access
Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma
SHOZO MORI, TAKU AOKI, YUHKI SAKURAOKA, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUKIHIRO ISO and KEIICHI KUBOTA

Anticancer Research March 2021, 41 (3) 1629-1639; DOI: https://doi.org/10.21873/anticanres.14925
You have access
Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 Study
AKIMITSU YAMADA, KYOKO NAKAZAWA, KOHEI AKAZAWA, KAZUTAKA NARUI, ITARU ENDO, YOSHIE HASEGAWA, NORIO KOHNO, TAKASHI ISHIKAWA and THE JONIE STUDY GROUP

Anticancer Research February 2021, 41 (2) 1063-1068; DOI: https://doi.org/10.21873/anticanres.14863
You have access
Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy
TAKASHI YOKOKAWA, KENICHI SUZUKI, TAKAHITO SUGISAKI, KAZUO KOBAYASHI, DAIGO SHOUJI, HIROSHI WATANABE, KAZUYOSHI KAWAKAMI, TOMOMI TAKIGUCHI, TAKESHI AOYAMA, KOKORO KOBAYASHI, SHUNJI TAKAHASHI, YOSHINORI ITO, SHINJI OHNO and TOSHIHIRO HAMA

Anticancer Research February 2020, 40 (2) 915-921; DOI: https://doi.org/10.21873/anticanres.14024
You have access
Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy
YOSHIKAZU KANAZAWA, ITSUO FUJITA, DIASUKE KAKINUMA, HIROKI ARAI, KUNIHIKO MATSUNO, TOMOHIRO SHIMODA, KAZUHIDE KO, SHUNJI KATO and EIJI UCHIDA

Anticancer Research May 2017, 37 (5) 2715-2720;

Main menu

User menu

Search

relative dose intensity